fromAxios
1 week agoFDA approves first GLP-1 pill for weight loss
The big picture: The Danish drugmaker said participants in a 64-week clinical trial saw an average weight loss of about 17% if they stayed on the daily pill, reduced their calorie intake and increased exercise. That's compared to 3% average weight loss among trial participants who received a placebo. Between the lines: The active ingredient in oral Wegovy will be manufactured in North Carolina, Novo Nordisk said.
Medicine































